FIGURE 1.

Clinical course and treatment regimen in anti‐N‐methyl‐D‐aspartate receptor encephalitis patients. (a–f) Disease course, treatment regimens, and clinical milestones. Y‐axes are scaled logarithmically. AB, antibody; CSF, cerebrospinal fluid; CYC, cyclophosphamide; D, discharge from the hospital; F, female; FU, follow‐up; HDMP, high‐dose methylprednisolone; ICU, intensive care unit; IQR, interquartile range; IVIG, intravenous immunoglobulin; KI, Karnofsky index; M, marked clinical improvement; MTX, methotrexate; MMF, mycophenolate mofetil; NFL, neurofilament light chains; NMDAR, anti‐N‐methyl‐D‐aspartate receptor; O, onset of disease; PLEX/IA, plasma exchange or immunoadsorption [Colour figure can be viewed at wileyonlinelibrary.com]